An interventional study of ultrasound guidance in Ultrasound Guided Injection, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2019-06-11.
Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment
Evaluates the efficacy of ultrasound guided versus clinically guided steroid injection in the management of tenosynovitis in DM patients.
The current study will based on follow up study, conducted among patients presenting at outpatient rheumatology clinics of Al-Azhar University Hospitals, Egypt. with Diabetes mellitus duration at least 3 years and tenosynovitis of hand tendons with Richie tenderness grade 3.
All patients will randomized in two groups: Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance. Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance.
The affected tendons will scanned and scored for inflammation using ultrasound in all patients before the triamcinolone injection and then to be reassessed one month after the injection to determine the change in the tendons in both groups.
17 studies on the registry are indexed under Tenosynovitis; 4 are open to participants now.
This study's enrollment of 52 is close to the median of 52 across 13 interventional studies indexed under Tenosynovitis.
Browse Tenosynovitis studies →Al-Azhar University is the lead sponsor of 531 studies on the registry; 172 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Diabetes mellitus.
Exclusion Criteria:
Patients with recent hand trauma.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
* Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance.
Procedure: ultrasound guidance
Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance.
ultrasound guidance of tendon injection
change in Tenosynovitis pain
changes in VAS scale for pain,
Time frame: one month
change in Tenosynovitis tenderness
changes in Richie index for tenderness.
Time frame: one month
changes in ultrasound images of the Tenoasynovitis.
changes in Gery scale images, and power Doppler images of the tendons
Time frame: one month
Plan to share: No
No publications or documents are linked to this record.
Ran from Dec 2018 to primary completion in Jan 2019, 1 month.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.